Iovance Biotherapeutics
IOVA
IOVA
87 hedge funds and large institutions have $345M invested in Iovance Biotherapeutics in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
32% less call options, than puts
Call options by funds: $2.05M | Put options by funds: $3.02M
Holders
87
Holding in Top 10
3
Calls
$2.05M
Puts
$3.02M
Top Buyers
| 1 | +$21.1M | |
| 2 | +$4.03M | |
| 3 | +$2.91M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$1.83M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.04M |
Top Sellers
| 1 | -$7.53M | |
| 2 | -$4.16M | |
| 3 | -$3.96M | |
| 4 |
QF
QVT Financial
New York
|
-$1.74M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.58M |